INO
Price
$2.11
Change
-$0.14 (-6.22%)
Updated
Jun 27 closing price
Capitalization
77.38M
KRYS
Price
$138.88
Change
-$3.70 (-2.60%)
Updated
Jun 27 closing price
Capitalization
4.01B
43 days until earnings call
Interact to see
Advertisement

INO vs KRYS

Header iconINO vs KRYS Comparison
Open Charts INO vs KRYSBanner chart's image
Inovio Pharmaceuticals
Price$2.11
Change-$0.14 (-6.22%)
Volume$4.79M
Capitalization77.38M
Krystal Biotech
Price$138.88
Change-$3.70 (-2.60%)
Volume$418.51K
Capitalization4.01B
INO vs KRYS Comparison Chart in %
Loading...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INO vs. KRYS commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INO is a Hold and KRYS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (INO: $2.11 vs. KRYS: $138.88)
Brand notoriety: INO: Notable vs. KRYS: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INO: 707% vs. KRYS: 112%
Market capitalization -- INO: $77.38M vs. KRYS: $4.01B
INO [@Biotechnology] is valued at $77.38M. KRYS’s [@Biotechnology] market capitalization is $4.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INO’s FA Score shows that 0 FA rating(s) are green whileKRYS’s FA Score has 0 green FA rating(s).

  • INO’s FA Score: 0 green, 5 red.
  • KRYS’s FA Score: 0 green, 5 red.
According to our system of comparison, KRYS is a better buy in the long-term than INO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INO’s TA Score shows that 6 TA indicator(s) are bullish while KRYS’s TA Score has 4 bullish TA indicator(s).

  • INO’s TA Score: 6 bullish, 2 bearish.
  • KRYS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, INO is a better buy in the short-term than KRYS.

Price Growth

INO (@Biotechnology) experienced а +7.65% price change this week, while KRYS (@Biotechnology) price change was +4.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

KRYS is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($4.01B) has a higher market cap than INO($77.4M). INO YTD gains are higher at: 18.539 vs. KRYS (-11.349). KRYS has higher annual earnings (EBITDA): 140M vs. INO (-93.37M). KRYS has more cash in the bank: 617M vs. INO (68.4M). KRYS has less debt than INO: KRYS (9.66M) vs INO (11.3M). KRYS has higher revenues than INO: KRYS (333M) vs INO (283K).
INOKRYSINO / KRYS
Capitalization77.4M4.01B2%
EBITDA-93.37M140M-67%
Gain YTD18.539-11.349-163%
P/E RatioN/A33.30-
Revenue283K333M0%
Total Cash68.4M617M11%
Total Debt11.3M9.66M117%
FUNDAMENTALS RATINGS
INO vs KRYS: Fundamental Ratings
INO
KRYS
OUTLOOK RATING
1..100
6639
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
71
Overvalued
PROFIT vs RISK RATING
1..100
10041
SMR RATING
1..100
9957
PRICE GROWTH RATING
1..100
5662
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INO's Valuation (59) in the Medical Specialties industry is in the same range as KRYS (71) in the Pharmaceuticals Major industry. This means that INO’s stock grew similarly to KRYS’s over the last 12 months.

KRYS's Profit vs Risk Rating (41) in the Pharmaceuticals Major industry is somewhat better than the same rating for INO (100) in the Medical Specialties industry. This means that KRYS’s stock grew somewhat faster than INO’s over the last 12 months.

KRYS's SMR Rating (57) in the Pharmaceuticals Major industry is somewhat better than the same rating for INO (99) in the Medical Specialties industry. This means that KRYS’s stock grew somewhat faster than INO’s over the last 12 months.

INO's Price Growth Rating (56) in the Medical Specialties industry is in the same range as KRYS (62) in the Pharmaceuticals Major industry. This means that INO’s stock grew similarly to KRYS’s over the last 12 months.

KRYS's P/E Growth Rating (98) in the Pharmaceuticals Major industry is in the same range as INO (100) in the Medical Specialties industry. This means that KRYS’s stock grew similarly to INO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INOKRYS
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
Bullish Trend 3 days ago
64%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 10 days ago
77%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 13 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
80%
Aroon
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKHCF18.260.25
+1.39%
Sonic Healthcare Ltd.
OBGRF1.04N/A
N/A
Orbit Garant Drilling, Inc.
PTTWF2.05N/A
N/A
Orange Polska SA
FMCCO19.85-0.15
-0.77%
Freddie Mac
SLNCF1.60-0.05
-3.03%
Silence Therapeutics, Plc.

INO and

Correlation & Price change

A.I.dvisor indicates that over the last year, INO has been loosely correlated with RPTX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if INO jumps, then RPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INO
1D Price
Change %
INO100%
-6.22%
RPTX - INO
58%
Loosely correlated
-1.42%
BCYC - INO
55%
Loosely correlated
-0.55%
CLDX - INO
46%
Loosely correlated
-4.16%
DNLI - INO
45%
Loosely correlated
-2.69%
EYPT - INO
44%
Loosely correlated
-7.04%
More

KRYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with XNCR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
-2.60%
XNCR - KRYS
54%
Loosely correlated
-3.10%
IDYA - KRYS
54%
Loosely correlated
-4.13%
CRNX - KRYS
54%
Loosely correlated
-0.10%
ACLX - KRYS
54%
Loosely correlated
+0.90%
CGON - KRYS
54%
Loosely correlated
-0.46%
More